Evolving Strategies in Lymphedema Surgery
Clinical Lymphology and Lymphedema · 2026-05 · 11 (1) · 38-40
DOI: 10.67326/cll.2026.11.1.38 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lymphology and Lymphedema, online erschienen am 22.05.2026. Verfasst von Hyung Hwa Jeong.
Abstract (Originalsprache)
The surgical management of lymphedema has evolved substantially, shifting from ablative approaches toward physiologic reconstruction aimed at restoring lymphatic drainage. Ablative procedures, including suction-assisted liposuction and excisional techniques, continue to play a meaningful role in symptom control and may be combined synergistically with physiologic surgery. Physiologic procedures — principally lymphaticovenular anastomosis (LVA) — are most effective in early-stage disease, where residual lymphatic function remains intact. Emerging adjunctive therapies, including nanofibrillar collagen scaffolds aim to promote lymphangiogenesis and extend the reach of physiologic reconstruction. A comprehensive, stage-specific treatment algorithm integrating these modalities represents the foremost goal in advancing lymphatic surgery.
Zitieren
APA
Jeong, H. H. (2026). Evolving Strategies in Lymphedema Surgery. Clinical Lymphology and Lymphedema, 11(1), 38-40. https://doi.org/10.67326/cll.2026.11.1.38
Vancouver
Jeong HH. Evolving Strategies in Lymphedema Surgery. Clinical Lymphology and Lymphedema. 2026;11(1):38-40. doi:10.67326/cll.2026.11.1.38
BibTeX
@article{Jeong2026,
author = {Jeong, Hyung Hwa},
title = {Evolving Strategies in Lymphedema Surgery},
journal = {Clinical Lymphology and Lymphedema},
year = {2026},
volume = {11},
number = {1},
pages = {38--40},
doi = {10.67326/cll.2026.11.1.38}
}
EUVIMED